---
title: "Senseonics Holdings, Inc. (SENS.US)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/SENS.US.md"
symbol: "SENS.US"
name: "Senseonics Holdings, Inc."
industry: "Health Care Equipment"
datetime: "2026-06-13T16:29:30.659Z"
locales:
  - [en](https://longbridge.com/en/quote/SENS.US.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/SENS.US.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/SENS.US.md)
---

# Senseonics Holdings, Inc. (SENS.US)

## Company Overview

Senseonics Holdings, Inc., a commercial-stage medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. Its products include Eversense, Eversense XL, Eversense E3, and Eversense 365, which are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and an app for real-time diabetes monitoring and management. The company serves healthcare providers and patients through a network of distributors and strategic fulfillment partners. Senseonics Holdings, Inc.

| Item | Detail |
|------|--------|
| Industry | Health Care Equipment |
| Exchange | US Market |
| Website | [www.senseonics.com](https://www.senseonics.com) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: C
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 2026-06-13T04:30:13.000Z

**Overall: C (0.54)**

**Industry**: Health Care Equipment

| Metric | Value |
|--------|-------|
| Industry Ranking | 75 / 184 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Growth - Stocks whose main business is in the growth stage.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

**Multi Score**: C

#### Style Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 71.91% |  |
| Net Profit YoY | -17.82% |  |
| P/B Ratio | 6.14 |  |
| Dividend Ratio | 0.00% |  |

#### Size Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 374817288.70 |  |
| Revenue | 40711000.00 |  |

#### Multi Score Score: C

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | -250.78% | E |
| Profit Margin | -214.16% | E |
| Gross Margin | 59.26% | B |
| Revenue YoY | 71.91% | A |
| Net Profit YoY | -17.82% | D |
| Total Assets YoY | 17.94% | A |
| Net Assets YoY | -2.45% | D |
| Cash Flow Margin | 0.00% | D |
| OCF YoY | 71.91% | A |
| Turnover | 0.43 | C |
| Gearing Ratio | 66.62% | D |

```chart-data:radar
{
  "title": "Longbridge Financial Score - Senseonics Holdings, Inc.",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Style Score",
      "grade": "",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "71.91%",
          "rating": ""
        },
        {
          "name": "Net Profit YoY",
          "value": "-17.82%",
          "rating": ""
        },
        {
          "name": "P/B Ratio",
          "value": "6.14",
          "rating": ""
        },
        {
          "name": "Dividend Ratio",
          "value": "0.00%",
          "rating": ""
        }
      ]
    },
    {
      "name": "Size Score",
      "grade": "",
      "indicators": [
        {
          "name": "Market Cap",
          "value": "374817288.70",
          "rating": ""
        },
        {
          "name": "Revenue",
          "value": "40711000.00",
          "rating": ""
        }
      ]
    },
    {
      "name": "Multi Score",
      "grade": "C",
      "indicators": [
        {
          "name": "ROE",
          "value": "-250.78%",
          "rating": "E"
        },
        {
          "name": "Profit Margin",
          "value": "-214.16%",
          "rating": "E"
        },
        {
          "name": "Gross Margin",
          "value": "59.26%",
          "rating": "B"
        },
        {
          "name": "Revenue YoY",
          "value": "71.91%",
          "rating": "A"
        },
        {
          "name": "Net Profit YoY",
          "value": "-17.82%",
          "rating": "D"
        },
        {
          "name": "Total Assets YoY",
          "value": "17.94%",
          "rating": "A"
        },
        {
          "name": "Net Assets YoY",
          "value": "-2.45%",
          "rating": "D"
        },
        {
          "name": "Cash Flow Margin",
          "value": "0.00%",
          "rating": "D"
        },
        {
          "name": "OCF YoY",
          "value": "71.91%",
          "rating": "A"
        },
        {
          "name": "Turnover",
          "value": "0.43",
          "rating": "C"
        },
        {
          "name": "Gearing Ratio",
          "value": "66.62%",
          "rating": "D"
        }
      ]
    }
  ]
}
```

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -5.42 | 116/184 | - | - | - |
| PB | 6.14 | 106/184 | 6.35 | 4.00 | 3.49 |
| PS (TTM) | 10.63 | 114/184 | 14.78 | 10.25 | 8.00 |
| Dividend Yield | 0.00% | - | - | - | - |

## Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 01 | Delcath (DCTH.US) | C | A | B | A | A | A |
| 02 | Electromed (ELMD.US) | A | B | A | A | B | A |
| 03 | Intuitive Surgical (ISRG.US) | A | B | C | A | B | B |
| 04 | Stryker (SYK.US) | A | C | C | C | B | B |
| 05 | Boston Scientific (BSX.US) | A | B | C | C | B | B |

## Institutional View

### Analyst Rating Distribution

> As of 2026-06-10T04:00:00.000Z

Total Analysts: **7**

| Rating | Count | Percentage |
|--------|-------|-----------| 
| Buy | 4 | 57% |
| Hold | 2 | 29% |
| Underweight | 1 | 14% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 7.18 |
| Highest Target | 20.00 |
| Lowest Target | 8.00 |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/SENS.US/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/SENS.US/norm.md)
- [Related News](https://longbridge.com/en/quote/SENS.US/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/SENS.US/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**